Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "brain hypersensitivity modulation" refers to strategies or interventions intended to alter abnormal brain network dynamics that underlie conditions like sensory overresponsivity and chronic pain. Research shows that hypersensitivity can result from an imbalance between excitatory and inhibitory neuronal activity or from abrupt, global synchronization events within brain networks ("explosive synchronization"). This phenomenon is not attributable to a single molecule or receptor, but involves distributed network properties, including changes in local structural connectivity and hub dynamics. Experimental modulation approaches include changing connectivity, either pharmacologically or with brain stimulation techniques, to reduce hypersensitivity observed in disorders such as fibromyalgia, autism, sensory modulation disorder, and migraine[1][2][3][4][5][6]. Summary: "Brain hypersensitivity modulation" is not a valid molecular target, receptor, or canonical molecule—it describes a distributed, emergent property of neural circuits and does not have a single molecular or protein target. The correct approach is to identify and refer to the specific circuits, neuronal types (such as inhibitory interneurons or excitatory neurons in the somatosensory cortex), or measurable network phenomena (such as E/I imbalance or explosive synchronization) involved in hypersensitivity conditions.
Modulation of excitatory/inhibitory (E/I) neuronal balance[1][4]; Alteration of network synchronization (explosive synchronization, ES)[2][3][5][6]; Brain stimulation (e.g., transcranial magnetic stimulation, deep brain stimulation) aimed at modulating network connectivity[2][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain hypersensitivity modulation.